PIEZO1 and cancer: Our research shows that PIEZO1 expression is positively correlated with key immune checkpoints, including CD274 (PD-L1), CTLA4, LAG3, PDCD1 (PD-1), PDCD1LG2 (PD-L2), and TIGIT across various cancer types.